The Oncology Institute, Inc. (NASDAQ:TOI – Get Rating) major shareholder Richy Agajanian sold 1,600,000 shares of the business’s stock in a transaction on Wednesday, May 11th. The shares were sold at an average price of $6.00, for a total transaction of $9,600,000.00. Following the sale, the insider now owns 253,436 shares of the company’s stock, valued at $1,520,616. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
NASDAQ:TOI opened at $6.12 on Friday. The Oncology Institute, Inc. has a one year low of $3.75 and a one year high of $12.66. The business has a fifty day moving average of $7.15.
Oncology Institute (NASDAQ:TOI – Get Rating) last posted its quarterly earnings data on Thursday, March 10th. The company reported $0.26 EPS for the quarter. The company had revenue of $52.30 million during the quarter.
Oncology Institute Company Profile (Get Rating)
The Oncology Institute, Inc, an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.
- Get a free copy of the StockNews.com research report on Oncology Institute (TOI)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.